- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT00004166
Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy
Amifostine as a Toxicity Protectant in Ovarian Cancer in Chemotherapy Treated Patients: A Pilot Phase III Randomized Controlled Trial
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Chemoprotective drugs such as amifostine may protect normal cells from the side effects of chemotherapy.
PURPOSE: Randomized phase III trial to study the effectiveness of amifostine in treating patients who have ovarian epithelial cancer and who are receiving chemotherapy.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
OBJECTIVES: I. Determine if patients with ovarian epithelial cancer receiving chemotherapy have significantly fewer neurologic events when treated with amifostine. II. Compare amifostine vs no chemoprotection in terms of overall incidence of neuropathy, incidence of neutropenia, infection, and other myelosuppressive events (e.g., leukopenia, anemia, and thrombocytopenia), length of hospital stay due to infections, and quality of life in this patient population.
OUTLINE: This is a randomized, parallel, controlled, double blind study. Patients are randomized to one of two treatment arms. Arm I: Patients receive amifostine IV over 10 minutes, 30 minutes prior to chemotherapy. Arm II: Patients receive a placebo IV over 10 minutes, 30 minutes prior to chemotherapy. Treatment repeats every 3 weeks for 8 courses in the absence of disease progression or unacceptable toxicity. Quality of life is assessed prior to courses 1, 4, and 8, and then every 3 months for 1 year. Patients are followed monthly for 6 months.
PROJECTED ACCRUAL: A total of 60 patients will be accrued for this study within 2 years.
Studietyp
Fas
- Fas 3
Kontakter och platser
Studieorter
-
-
Illinois
-
Chicago, Illinois, Förenta staterna, 60611
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
DISEASE CHARACTERISTICS: Histologically confirmed, surgically staged ovarian epithelial cancer Planned treatment with paclitaxel/carboplatinum chemotherapy
PATIENT CHARACTERISTICS: Age: 18 and over Performance status: GOG 0-2 Life expectancy: Not specified Hematopoietic: Absolute neutrophil count at least 1,500/mm3 Platelet count at least 100,000/mm3 Hepatic: Bilirubin no greater than 3 mg/dL SGOT/SGPT no greater than 2.5 times upper limit of normal Renal: Creatinine no greater than 2 mg/dL Other: Not pregnant or nursing Negative pregnancy test Fertile patients must use effective contraception during and for 3 months after study
PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: See Disease Characteristics No prior chemotherapy Endocrine therapy: Not specified Radiotherapy: No prior radiotherapy Surgery: See Disease Characteristics Other: At least 24 hours since prior antihypertensives
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Tilldelning: Randomiserad
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Utredare
- Studiestol: David A. Fishman, MD, Robert H. Lurie Cancer Center
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
- Neoplasmer efter histologisk typ
- Neoplasmer
- Urogenitala neoplasmer
- Neoplasmer efter plats
- Carcinom
- Neoplasmer, körtel och epitel
- Genitala neoplasmer, hona
- Sjukdomar i det endokrina systemet
- Ovariella sjukdomar
- Adnexala sjukdomar
- Gonadal sjukdomar
- Neoplasmer i endokrina körtel
- Ovariella neoplasmer
- Karcinom, äggstocksepitel
- Läkemedels fysiologiska effekter
- Skyddsmedel
- Strålskyddsmedel
- Amifostin
Andra studie-ID-nummer
- NU 97CC4
- NU-97CC4
- NCI-G99-1633
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Livskvalité
-
Marlene FischerAvslutadPostoperativ Quality of Recovery på Postanesthesia Care UnitTyskland
-
University of Southern DenmarkNaestved HospitalAvslutadHRQOL (Health Related Quality of Quality)Danmark
-
Anqing Municipal HospitalAvslutadDexmedetomidin | Lidokain | Quality of Recovery (QoR-40), Preoperativ och PostoperativKina
-
University of Southern DenmarkVejle Hospital; Vejle KommuneAvslutadHRQOL (Health Related Quality Of Life)Danmark
-
University Hospital, GrenobleOkändHealth Care Quality Management (inget villkor).Frankrike
-
University of MalayaOkändTranspalatal Arch (TPA) | Oral Health Related Quality of Life (OHRQoL) | Oral Health Impact Profile Short Version 14 (OHIP 14) | Ortodontisk smärta | Tredimensionell (3D) ortodontisk anordningMalaysia
-
Hospital Italiano de Buenos AiresAvslutadValideringsstudier | Tvärkulturell jämförelse | Journaler | Total Quality ManagementArgentina
-
Northwestern UniversityUniversity of Wisconsin, StoutAvslutadPerception of Skin of Color Clinics in African AmericansFörenta staterna
-
Prisma Health-UpstateNational Institute on Drug Abuse (NIDA); Clemson UniversityRekryteringVårdstandard | Standard of Care + CBT4CBT | Standard of Care + CBT4CBT + RCFörenta staterna
-
Aalborg UniversityThe General Practice Foundation in Denmark (grant number A3495); The Novo... och andra samarbetspartnersRekrytering
Kliniska prövningar på amifostintrihydrat
-
National Cancer Institute (NCI)AvslutadProstatiska neoplasmerFörenta staterna
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)AvslutadLivmoderhalscancer | StrålningstoxicitetFörenta staterna
-
Sun Yat-sen UniversityDalian Merro Pharmaceutical Co. LtdOkändBenmärgssjukdomar | Nasofaryngeala neoplasmer | Mukosit | SpottkörtelsjukdomarKina
-
The Dale & Frances Hughes Cancer CenterMedImmune LLCAvslutadHuvud- och halscancer | LungcancerFörenta staterna
-
Mt. Sinai Medical Center, MiamiMedImmune LLCAvslutad
-
University of IowaAvslutad
-
PENTA FoundationChiesi Farmaceutici S.p.A.AvslutadHjärnhinneinflammationStorbritannien
-
Cancer Institute and Hospital, Chinese Academy...Okänd
-
Sun Pharmaceutical Industries LimitedIndragenStomatit | Oral mukosit
-
Dana-Farber Cancer InstituteOkändFanconis anemiFörenta staterna